LOSARTAN POTASSIUM
- Product NDC
- 72189-317
- 11-digit product format
- 721890317
- Labeler code
- 72189
- Product ID
- 72189-317_d6e3191f-ead4-6245-e053-2a95a90a0b53
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LOSARTAN POTASSIUM
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DirectRx
- Application
- ANDA077459
- Marketing category
- ANDA
- Marketing start
- 2022-01-19
- Marketing end
- 0000-00-00
- Substance
- LOSARTAN POTASSIUM
- Active strength
- 100 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72189-317-30 | LOSARTAN POTASSIUM | 30 in 1 BOTTLE | TABLET | 30 | | 3 |
| 72189-317-90 | LOSARTAN POTASSIUM | 90 in 1 BOTTLE | TABLET | 90 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72189-317 | LOSARTAN POTASSIUM TABLET [DIRECTRX] | 3 | Legacy NDC, 2 package rows | 20230707_d5f17655-cfc6-6f76-e053-2a95a90a2352.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72189-317-30 | 72189031730 | 30 TABLET in 1 BOTTLE (72189-317-30) | 30 tablet | 2022-01-19 | 0000-00-00 | No | No | Current |
| 72189-317-90 | 72189031790 | 90 TABLET in 1 BOTTLE (72189-317-90) | 90 tablet | 2022-01-19 | 0000-00-00 | No | No | Current |